Need a specific person's email?
Browse Cellectis's employee directory (about 242 employees) and reveal verified emails free.
Cellectis's most common email format is First.Last@cellectis.com (ex. John.Doe@cellectis.com), used for 79% of cellectis.com addresses. Cellectis uses 4 email patterns.
| Format | Example | Share of cellectis.com |
|---|---|---|
| First.Last@cellectis.comMost common | John.Doe@cellectis.com | |
| FLast@cellectis.com | JDoe@cellectis.com | |
| First.Middle@cellectis.com | John.Michael@cellectis.com | |
| Last@cellectis.com | Doe@cellectis.com |
Browse Cellectis's employee directory (about 242 employees) and reveal verified emails free.
Biotechnology ResearchÎle-de-France, France201-500 Employees
Cellectis is a global clinical-stage biotechnology company focused on developing cell and gene therapies using a genome editing platform. It concentrates on immuno-oncology and gene therapy by engineering allogeneic CAR-T cells designed to recognize and eliminate cancer cells. The firm is advancing two lead clinical programs for relapsed or refractory B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. It maintains end-to-end manufacturing control through a vertically integrated model, producing starting materials in Paris, Île-de-France, and finished CAR-T products in Raleigh, North Carolina. Headquartered in Paris, with additional sites in New York and Raleigh, the company collaborates with industry partners and is listed on Nasdaq and Euronext Growth. A notable recent development is that the FDA granted RMAT designation to lasme-cel, its CD22-targeting allogeneic CAR-T therapy, for relapsed or refractory B-cell ALL.
Most common format
First.Last@cellectis.com
Example: John.Doe@cellectis.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.